Sodium hydride → HCID 67341254, compound
Reaction equation
[H-].[Na+].[C:3]([O:7][CH3:8])(=[O:6])[CH2:4][OH:5].CS(O[CH2:14][CH:15]1[CH2:20][CH2:19][N:18]([C:21]2[CH:22]=[CH:23][C:24]3[N:25]([C:27]([C:30]([F:33])([F:32])[F:31])=[N:28][N:29]=3)[N:26]=2)[CH2:17][CH2:16]1)(=O)=O>>[F:33][C:30]([F:31])([F:32])[C:27]1[N:25]2[N:26]=[C:21]([N:18]3[CH2:17][CH2:16][CH:15]([CH2:14][O:5][CH2:4][C:3]([O:7][CH3:8])=[O:6])[CH2:20][CH2:19]3)[CH:22]=[CH:23][C:24]2=[N:29][N:28]=1Participants
Conditions
- Temperature
- 100 °C
Procedure
Sodium hydride (60% dispersion in oil, 0.120 g, 3.0 mmol) was added to neat methyl glycolate (1.544 mL, 20.0 mmol). When the effervescence had subsided 6-[4-(methanesulfonyloxymethyl)piperidin-1-yl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine (0.759 g, 2.0 mmol) was added and the mixture was heated at 100° C. for 40 minutes. The reaction mixture was partitioned between DCM and water. The organic phase was washed with water and brine, dried over MgSO4 and evaporated. The product was isolated by MPLC silica chromatography, eluting with ethyl acetate. The product containing fractions were evaporated to an oil which crystallised from ether, giving methyl 2-[[1-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]methoxy]acetate (0.130 g, 17%).
Workup
- additionwas added
- customThe reaction mixture was partitioned between DCM and water
- washThe organic phase was washed with water and brine
- dry with materialdried over MgSO4
- customevaporated
- customThe product was isolated by MPLC silica chromatography
- washeluting with ethyl acetate
- additionThe product containing fractions
- customwere evaporated to an oil which
- customcrystallised from ether
Sources & evidence
- ORD record
- ord-72ce27f724bb4c43851e3a463d05ce67
- Source dataset
- uspto-grants-2011_08
- Patent number
- US08003649B2
Reaction notes
Loading…